Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: Clinical activity and biological correlations

M. Cristofanilli*, P. Morandi, S. Krishnamurthy, J. M. Reuben, B. N. Lee, D. Francis, D. J. Booser, M. C. Green, B. K. Arun, L. Pusztai, A. Lopez, R. Islam, V. Valero, G. N. Hortobagyi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Fingerprint Dive into the research topics of 'Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: Clinical activity and biological correlations'. Together they form a unique fingerprint.

Medicine & Life Sciences